{"id":126014,"title":"DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T11:06:43.541000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/52247.html?wbdisable=false","snippet":"DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services Departments Language selection Français Search and menus Search and menus Canadian Institutes…","rawSnapshotUrl":"/api/snapshots/raw/126014","browseUrl":"https://replay.healtharchive.ca/job-2/20250410110643/https://cihr-irsc.gc.ca/e/52247.html?wbdisable=false#ha_snapshot=126014","mimeType":"text/html","statusCode":200}